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Preparations of parainfluenza virus 5 (PIV5) that are potent activators of the interferon (IFN) induction cascade were generated
by high-multiplicity passage in order to accumulate defective interfering virus genomes (DIs). Nucleocapsid RNA from these
virus preparations was extracted and subjected to deep sequencing. Sequencing data were analyzed using methods designed to
detect internal deletion and “copyback” DIs in order to identify and characterize the different DIs present and to approximately
quantify the ratio of defective to nondefective genomes. Trailer copybacks dominated the DI populations in IFN-inducing prepa-
rations of both the PIV5 wild type (wt) and PIV5-VC (a recombinant virus that does not encode a functional V protein). Al-
though the PIV5 V protein is an efficient inhibitor of the IFN induction cascade, we show that nondefective PIV5 wt is unable to
prevent activation of the IFN response by coinfecting copyback DIs due to the interfering effects of copyback DIs on nondefec-
tive virus protein expression. As a result, copyback DIs are able to very rapidly activate the IFN induction cascade prior to the
expression of detectable levels of V protein by coinfecting nondefective virus.
The interferon (IFN) response is extremely potent at restrictingvirus replication and spread prior to activation of the adaptive
immune system. IFN- and - are synthesized and secreted from
cells in response to virus infection, and this leads to the establish-
ment of an antiviral state in the infected cell and neighboring
uninfected cells through the upregulation of hundreds of IFN-
stimulated genes (ISGs) that together function to make the cell a
hostile environment for virus replication. Triggering of the IFN-
promoter during infection with paramyxoviruses and other neg-
ative-sense viruses occurs through activation of cytosolic pattern
recognition receptors (PRRs). The best characterized of these are
RIG-I and mda-5, which become activated upon binding of viral
pathogen-associated molecular patterns (PAMPs). The viral
PAMPs that activate RIG-I and mda-5 are viral RNA molecules;
RIG-I is thought to recognize primarily short double-stranded
RNAs (dsRNAs) with an uncapped triphosphate moiety, while
mda-5 is activated by longer dsRNAs (1–6). Following their acti-
vation by PAMP binding, RIG-I and mda-5 elicit a downstream
signaling cascade that culminates in the nuclear translocation of
the IFN regulatory factor 3 (IRF3) and NF-B transcription fac-
tors and subsequent transcription from the IFN- gene. In order
to circumvent the powerful IFN response, most viruses have
evolved mechanisms to evade it, by encoding viral factors that
inhibit IFN induction, the ability of IFN to upregulate ISGs, or the
function of certain ISG products (reviewed in reference 7).
Parainfluenza virus 5 (PIV5; formerly simian virus 5 [SV5]) is
a prototype member of the genus Rubulavirus in the Paramyxo-
viridae family. The15-kb negative-sense genomic RNA encodes
eight gene products from its seven genes and carries noncoding
leader (Le) and trailer (Tr) sequences at its 3= and 5= ends, respec-
tively, that are essential for the control of transcription and repli-
cation. Early in infection, the 3= genomic promoter directs synthe-
sis of both viral mRNAs and antigenomes (the full-length
complement of the genome) using genomic RNA as a template.
Antigenomes serve as a template for the generation of progeny
genomic RNA from the antigenomic (Tr=) promoter later in in-
fection. The antigenomic promoter is thought to be stronger than
the genomic promoter, reflecting the requirement of the virus to
generate greater numbers of genomes than antigenomes (8).
Paramyxoviruses are known to spontaneously generate defec-
tive interfering virus genomes (DIs) due to errors during replica-
tion. These DIs are subgenomic and contain deletions (often ex-
tensive) that render the virus unable to complete a full replication
cycle in the absence of a coinfecting, nondefective “helper” virus.
Paramyxovirus DIs may be internal deletion or “copyback” in
nature, and these two types of DIs differ considerably in their
genome structures. Internal deletion DIs retain the Le and Tr se-
quences of the genome and therefore possess transcription and
replication signals and have been shown to generate viral transla-
tion products (9, 10). In contrast, the 3= genomic promoter in
trailer copyback DI [DI(TrCB)] genomes has been replaced by a
sequence complementary to the 5= antigenomic promoter due to
template switching from the antigenome to the nascent strand
during synthesis of genomic RNA; the termini of DI(TrCB)s are
thus complementary and form a dsRNA stem-loop structure
when SDS treatment is used to dissociate the RNA genomes from
encapsidating NP protein (11). This structure is thought to be
responsible for the ability of DI(TrCB)s to act as potent inducers
of IFN (12–15). DIs also efficiently inhibit the replication of non-
defective genomes due to the replicative advantage conferred by
their smaller size or through successful competition for viral or
host factors that are required for genome replication (reviewed in
reference 16). The substitution of the weak genomic promoter for
the stronger antigenomic promoter in DI(TrCB) genomes addi-
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tionally confers a significant replicative advantage over nondefec-
tive virus genomes, and this leads to their accumulation in virus
stocks that are generated at high multiplicity.
To enable examination of IFN- promoter activation in indi-
vidual infected cells, we have generated an A549 cell line, A549/
pr.IFN-.GFP, which expresses green fluorescent protein (GFP)
under the control of the IFN- promoter and have shown that
these cells faithfully report activation of the IFN induction cascade
(14, 17). Following infection of these cells with a range of negative-
sense RNA viruses (including PIV5, mumps virus, and influenza A
virus), only a small minority of infected cells ever expressed GFP,
indicating “heterocellular” activation of the IFN-promoter (17).
PIV5 encodes a potent IFN antagonist, the V protein, which tar-
gets the IFN induction cascade at multiple levels through inhibi-
tion of mda-5 and RIG-I activity and by acting as an alternative
substrate for the IRF3 kinases TBK1 and IB kinase ε (IKKε) (18–
21). However, PIV5-VC, a recombinant PIV5 that does not ex-
press a functional IFN antagonist due to an extensive deletion in
the V gene (22), also failed to activate the IFN- promoter in the
majority of infected cells (14). This led us to suggest that the viral
PAMPs capable of activating the IFN induction cascade are not
usually generated during the normal replication cycle of PIV5.
Instead, activation of the IFN induction cascade appears to be
associated primarily with the presence of DIs, since infection with
DI-rich preparations of mumps virus or PIV5-VC rich in DIs
could efficiently activate the IFN- promoter in the majority of
cells (14, 17). In this study, we generated preparations of PIV5-
VC and the PIV5 wild type (wt) that are either poor or efficient
inducers of IFN and subsequently used extensive deep sequencing
analyses to identify and characterize the DIs present in these prep-
arations.
MATERIALS AND METHODS
Cells, viruses, and IFN. Vero cells, A549 cells, and their derivatives were
grown as monolayers in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum at 37°C. PIV5 (strain W3A
[23]) and PIV5-VC (22) were grown and titrated under appropriate
conditions in Vero cells. Virus infections were carried out in DMEM
supplemented with 2% fetal bovine serum. The construction and proper-
ties of the A549/pr(IFN-).GFP cell line have been described extensively
(14, 17). IFN- (Roferon A; Roche) was used at 1,000 IU/ml.
Generation of DI-rich virus preparations. DI virus-rich stocks of
PIV5-VC and PIV5 wt were generated essentially as described previously
(14). Briefly, Vero cells grown in 75-cm2 flasks were infected at a multi-
plicity of infection (MOI) of 5 PFU/cell with working stocks (vM0). The
culture medium was harvested every 2 to 3 days: half was frozen at70°C
for subsequent analysis, while the other half was used to infect another
75-cm2 flask. Sequential preparations of these stocks are referred to as
vM1, vM2, etc.
Immunofluorescence, immunoblotting, immunoprecipitation, and
FACS analysis. The procedures for immunoblotting, immunofluores-
cence, and immunoprecipitation have been described previously (18, 24).
Antibodies used in these procedures included monoclonal antibodies
against the PIV5 NP, P, M, HN, and L proteins (25), PIV5 V (raised
against the C terminus; a kind gift from R. Lamb), phospho-IRF3 (Cell
Signaling Technology), GFP (Roche), and -actin (Sigma). The poly-
clonal antibodies used included those raised against ISG56 (Santa Cruz)
and MxA (Santa Cruz). Immunofluorescence was examined using a
Nikon Microphot-FXA immunofluorescence microscope or a Zeiss LSM
5 Exciter confocal microscope. For fluorescence-activated cell sorter
(FACS) analysis, A549/pr(IFN-).GFP cells were trypsinized to obtain a
single-cell suspension and fixed in phosphate-buffered saline (PBS)–5%
formaldehyde. Cells were then permeabilized and stained with anti-NP
antibody and phycoerythrin-conjugated secondary antibody to deter-
mine PIV5 protein expression. Expression of GFP and NP was examined
using a BD FACScan flow cytometer.
Interferon assays. The amount of IFN secreted by cells was estimated
by a cytopathic effect (CPE) reduction bioassay. Briefly, culture superna-
tants were harvested from infected cell monolayers, centrifuged at 1,500
g for 10 min to pellet cellular debris, UV treated to inactivate residual
virus, and then serially diluted 2-fold and added to monolayers of cells of
the bovine diarrhea virus NPro-expressing cell line A549/BVDV-NPro
(26) for 18 h prior to infection with encephalomyocarditis virus (EMCV)
(0.05 PFU/cell). Monolayers were fixed 2 to 3 days postinfection (p.i.)
(with PBS–5% formaldehyde), and CPE was monitored by staining with
0.1% crystal violet.
Isolation of RNA from purified RNPs and deep sequencing. Viral
RNPs were purified using an adaptation of a published protocol adapted
from reference 27. Following high-multiplicity passage of virus in 300-
cm2 flasks, culture supernatants were harvested from infected cell mono-
layers and used in assays to test activation of the IFN response. Infected
cells were harvested from culture flasks using glass beads, washed with
PBS, and pelleted at 700  g for 10 min. The pellet was resuspended in
ice-cold lysis buffer (150 mM NaCl, 50 mM Tris-HCl [pH 7.5], 0.6%
NP-40 supplemented with protease inhibitor tablets [Roche]), incubated
for 5 min, and then centrifuged at 4,200 g for 5 min at 4°C. The super-
natant was collected and held on ice, and the EDTA concentration was
adjusted to 6 mM EDTA. Linear 30 to 35% cesium chloride gradients were
prepared, overlaid with the cell extracts, and centrifuged overnight at
175,000 g at 12°C. Nucleocapsid bands were harvested, and the associ-
ated RNA was isolated using TRIzol (Invitrogen) according to the manu-
facturer’s instructions. Viral RNA isolated from PIV5 RNPs was se-
quenced in the Glasgow Polyomics Facility, University of Glasgow, using
an Illumina GA2x platform. Reads were aligned to PIV5-VC and wild-
type PIV5 (as appropriate to the source of the sample) using BWA (28)
and visualized using Tablet (29).
Analysis of PIV5DI genomes. Illumina sequence reads containing DI
breakpoints were detected and processed using a variant of the method
used previously to detect splice junctions (30). The following steps were
performed entirely using custom-made Perl scripts.
Detection of candidate reads spanning breakpoints. Each FASTQ-
formatted read was converted to FASTA format. The read was then
aligned with the reference genome sequence using a regular-expression-
based (regexp) method. Candidates for reads spanning a breakpoint were
required to match two parts of the reference genome on either strand,
with precise matching extending in each part for at least 21 nucleotides
(nt). Four kinds of breakpoint were identified: (i) left copyback (DI), in
which the left part of the read maps to the top strand of the reference
genome and the right end maps to the complementary strand; (ii) right
copyback [DI(TrCB)], which is the converse of left copyback; (iii) internal
deletions, in which the left and right parts map to the same strand and are
separated by at least 1 nt; and (iv) duplications, in which the left and right
parts map to the same strand but the former is further downstream than
the right. On the identification of a candidate breakpoint, the 17 nt on
either side of the breakpoint were selected from the reference genome to
make a 34-mer representing that particular break. This value was chosen
on the basis that 17 is the shortest uniquely occurring sequence in the
PIV5 genome (defined using the application Repeat from the GCG v.11.1-
UNIX suite [31]). At the same time, a 112-mer was constructed by select-
ing 56 nt on either side of the break. The process outlined above was
performed three times: on the original FASTQ-formatted reads and on
the same reads trimmed at the 3= end by 10 nt and then 15 nt. Since
read-calling confidence decreased toward the 3= end of each read, use of
these trimmed sets found extra breakpoints that were not found by using
the full-length reads.
Collection of candidate breakpoints. After all candidate breakpoints
had been collected, these were trimmed for redundancy, leaving one
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unique 34-mer and its corresponding 112-mer for each. The original
FASTQ read file was then subsampled to retrieve all reads containing each
of the 34-mers, outputting a separate file for each candidate breakpoint.
This step was performed on 206-node CentOS compute cluster. Each
subsampled FASTQ file was aligned to its corresponding 112-mer se-
quence using Maq (32). This step enabled quantification of the number of
high-quality read matches to each candidate breakpoint, and the choice of
a 112-mer sequence for matching ensured that the sequences flanking the
breakpoint were unique in the reference genome. Note that any break-
point occurring within 56 nt of the genome ends would not have been
identified.
RESULTS
Generation of DI-rich PIV5 preparations. Our previous work
demonstrated that the DI content and IFN-inducing capacity of a
PIV5-VC preparation could be significantly increased by se-
quential high-multiplicity passage of the virus in Vero cells (which
do not produce IFN [33] and can therefore be used to propagate
both PIV5 wt and PIV5-VC). Thus, while a PIV5-VC prepara-
tion that had been generated by low-multiplicity passage so as to
limit the propagation of DIs (termed vM0) activated the IFN-
promoter in only 8% of infected A549/prIFN-.GFP reporter
cells, infection with a stock that had been generated by two high-
multiplicity passages (vM2) lead to the expression of GFP in over
80% of cells (Fig. 1A), consistent with an increase in other markers
of activation of the IFN response, including IFN secretion, IRF3
phosphorylation, and expression of ISGs (14).
Similarly, we generated preparations of PIV5 wt, which en-
codes a functional IFN antagonist, by high-multiplicity passages
in Vero cells and examined these virus stocks for their ability to
activate the IFN response. IFN secretion from infected cells and
GFP expression following infection of A549/pr(IFN-).GFP cells
with PIV5 wt vM0, vM3, vM6, vM9, and vM12 preparations are
shown in Fig. 1B. Both IFN secretion from infected cells and GFP
expression steadily increased with the number of high-multiplic-
ity passages until passages 9 to 12. Thus, monolayers infected with
PIV5 wt vM6 and vM12 secreted 128 and 512 relative units of IFN,
respectively, compared to 8 units for the vM0 preparation. The
increase in GFP expression with the number of high-multiplicity
passages could clearly be seen by both fluorescence microscopy
and FACS, which demonstrated that 87.9% of cells infected with
vM12 were positive for GFP compared to 2.81% for vM0. When
analyzed by immunoblotting, PIV5 wt vM6- and vM12-infected
cell lysates also exhibited considerably more IRF3 phosphoryla-
tion and GFP, ISG56, and MxA expression (the relevance of which
is discussed further below) than their vM0 counterpart (Fig. 1C).
Viruses that had been plaque purified from DI-rich PIV5 prepa-
rations and then amplified by low-MOI passage were comparable
with vM0 stocks in their ability to activate the IFN response, indi-
cating that it was the accumulation of DI viruses that led to an
increase in IFN induction and not any genetic change in the prop-
erties of the nondefective virus that may be associated with high-
MOI passage (data not shown). Thus, as we have shown previ-
ously for PIV5-VC (14), there is a clear correlation between
activation of the IFN- promoter and the presence of DIs in PIV5
wt preparations. Through the depletion or enrichment of DIs, it is
FIG 1 Activation of the IFN response by PIV5 preparations generated by high-multiplicity passage. A549/pr(IFN-).GFP reporter cells were infected with
equivalent dilutions of PIV5-VC vM0 or vM2 (A) or (B) PIV5 wt vM0, vM3, vM6, vM9, or vM12 (B). Sixteen hours later, the culture media were harvested and
the cells were fixed and immunostained for viral NP expression. Expression of GFP and virus proteins was analyzed by fluorescence microscopy (left panel).
Multiplicity (PFU/cell) for each virus is indicated by the number shown in the NP panel. The amount of IFN present in the culture media was estimated by
cell-based CPE reduction assay and is shown by the number in the GFP panel. Duplicate monolayers were trypsinized, fixed, and subjected to FACS analysis of
GFP expression (right panel). n.d., not determined. (C) A549 cells were left uninfected (UI) or were infected with an equivalent multiplicity of PIV5 wt vM0, vM6,
or vM12. Cell lysates were prepared 24 h later and subjected to SDS-PAGE and immunoblotting for phospho-IRF3 (p-IRF3), GFP, ISG56, MxA, viral NP, and
actin.
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therefore possible to generate stocks of PIV5 wt or PIV5-VC that
are either poor or good inducers of the IFN- promoter.
Sequence analysis of DI-rich PIV5 preparations. We next
performed deep sequencing analysis of selected virus prepara-
tions. Viral RNPs were isolated from infected cells, and the asso-
ciated RNA was sequenced on an Illumina GA2x platform, giving
sequencing reads 72 nt in length. Each read was mapped to the
PIV5-VC or PIV5 wt genome as appropriate. The frequencies of
reads at each nucleotide in the entire PIV5 genome for PIV5-VC
(vM0 and vM2 preparations) and the PIV5 wt (vM0 and vM12
preparations) are shown in Fig. 2A and B, respectively. For the
vM0 preparations of both viruses, approximately even coverage
was obtained across the whole genome, with averages of 105,068
reads per nt for PIV5 wt and 134,118 reads per nt for PIV5-VC
(equivalent to averages of 3,889 and 4,051 reads per base per mil-
lion reads for PIV5 wt and PIV5-VC, respectively). For the IFN-
inducing PIV5 preparations, PIV5-VC vM2 and PIV5 wt vM12,
however, the overwhelming majority of sequence reads mapped
to the 5= end of the genome, indicating an abundance of DI(TrCB)
genomes. A rough estimation of the number of DI(TrCB)s to
nondefective genomes was obtained by dividing the average num-
ber of reads per nt in the appropriate genome region (from nt
14000 to the 5= end of the genome for PIV5-VC vM2 and from nt
14500 to the 5= end of the genome for PIV5 wt vM12) by the
average reads per nucleotide in the genome prior to this point
(e.g., nt 1 to 13999 for PIV5-VC and nt 1 to 14499 for PIV5 wt).
Thus, there were approximately 19 DI(TrCB)s per nondefective
genome for PIV5-VC vM2 and 59 for PIV5 wt vM12. These
figures are likely to be an underestimate due to the low coverage at
the extremities of the genome that is inherent in the sequencing
process.
Detailed analysis of DI genomes in DI-rich PIV5 prepara-
tions. The mapping of sequence reads to a reference genome does
not permit identification of the location of the breakpoints that
FIG 2 Deep sequencing analyses of RNA isolated from PIV5-infected cells. Viral RNPs were extracted from Vero cells infected with PIV5-VC (A) or PIV5 wt
(B). Associated RNA was subjected to deep sequencing using the Illumina GA2x platform, and sequencing reads were mapped to PIV5-VC (A) or PIV5 wt (B)
reference genomes. The frequency of reads at each nucleotide is shown in red for vM0 virus preparations and in black for the DI-rich virus preparations
PIV5-VC vM2 (A) and PIV5 wt vM12 (B). Coverage from nt 14000 to 15246 is shown as an inset in order to highlight the peaks at the 5= end of the genome.
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gave rise to copyback or internal deletion DIs. To study the variety
of DI species present in the genome population and their relative
frequency in the DI population, the deep sequencing data were
analyzed using methods specifically designed to identify the
breakpoints that are associated with trailer copyback [DI(TrCB)],
leader copyback [DI(LeCB)], and internal deletion DIs. While
these analyses demonstrated an overwhelming enrichment of
DI(TrCB)s in PIV5 wt vM12 and PIV5-VC vM2, consistent with
the data presented in Fig. 2, we could also identify small numbers
of potential internal deletion, duplication, and DI(LeCB) ge-
nomes. However, these were present at very low proportions in
the DI population in the PIV5-VC vM2 and PIV5 wt vM12 prep-
arations and, importantly, unlike DI(TrCB), their relative num-
bers did not increase upon high-multiplicity passage, indicating
that they could not have contributed significantly to the IFN-
inducing capacity of our DI-rich virus preparations. Furthermore,
it is possible that at least some of the joins and deletions identified
at low frequencies are an artifact of the sequencing techniques
used, rather being derived from genuine DIs, and given their very
low numbers, we have not yet attempted to validate their existence
by other methods.
Analysis of the DI(TrCB) population indicated that, overall,
reads mapping onto DI(TrCB)s were 22 and 87 times more
abundant in PIV5-VC vM2 and PIV5 wt vM12, respectively,
than in the original virus stocks. Several different DI(TrCB) spe-
cies were detected in our virus preparations with various frequen-
cies: the most abundant species for PIV5-VC and PIV5 wt are
listed in Tables 1 and 2, respectively. For each unique DI(TrCB),
the position of the breakpoint is listed along with the predicted
total size of the DI, the length of the dsRNA stem-loop region, and
the percentage of the total DI(TrCB) population that it comprises.
These DI(TrCB)s varied considerably both in the total size of the
genome (468 to 1,427 nt in length) and the length of the predicted
dsRNA stem (89 to 412 nt). The points in the genome at which
these DI(TrCB)s were generated did not fall into a particular re-
gion within the Tr, suggesting that no area was substantially more
prone to template switching than others. The most prominent
PIV5-VC DI(TrCB) species, which made up 62% of the total
DI(TrCB) population in PIV5-VC vM2 (Table 1), was the one
that we identified and cloned by reverse transcription (RT)-PCR
previously (14). This DI(TrCB) was predicted to be 1,427 nt in
length with a breakpoint such that either nt 14043 is transposed
next to nt 15024 or nt 14044 is transposed to nt 15023 on the
opposite strand, giving a predicted dsRNA stem of 223 bp. (A 2-nt
redundancy makes it impossible to distinguish between these two
possibilities.) However, the original cloned DI(TrCB) fragment
we previously identified contained a single base insertion into the
loop of the structure, thus generating a molecule of 1,428 nt which
obeys the “rule of six” (34). Since we could not detect this inserted
base in the bulk of sequences generated by deep sequencing, we
repeated the DI cloning experiment and generated a further 14
clones. When these were sequenced, none of these had this base
insert and only 2 clones had base inserts or deletions, but neither
of these generated structures that obeyed the rule of six. The next
most common DI(TrCB) species, comprising 15% of the popula-
tion, was a much smaller DI, with a total length of 510 nt and a
predicted dsRNA stem of 89 bp. RT-PCR and conventional se-
quencing also validated the presence of this particular DI(TrCB)
in the preparation (data not shown). For PIV5 wt vM12, the most
abundant DI(TrCB) [94% of the DI(TrCB) population] had nt
14496 transposed next to nt 15062 on the opposite strand, giving a
total genome length of 936 nt and a predicted dsRNA stem of 184
bp (Table 2). The presence of both this DI(TrCB) and the second
most abundant species was confirmed by RT-PCR, and the result-
ing PCR products were sequenced and found to be identical to
those identified by deep sequencing (data not shown). An impor-
tant observation from these analyses was that the most abundant
DI(TrCB) species present in PIV5-VC vM2-infected cells could
not be detected in PIV5 wt vM12-infected cells and vice versa.
The effect of DI(TrCB)s on the IFN antagonistic properties
of nondefective PIV5. The data presented above clearly demon-
strate that high-multiplicity passage of PIV5 wt generates virus
preparations that are efficient at activating the IFN response and
that this ability correlates with an accumulation of DI(TrCB) ge-
nomes. These preparations activated the IFN- promoter in the
majority of cells, even in infections at a high multiplicity with
regard to infectious particles (i.e., nondefective virus) (Fig. 1B). As
such, every cell should have been infected with nondefective virus
that encodes a functional V protein, yet there was no inhibition of
IFN induction in these cells. It was also clear from these infections
that, in addition to robust activation of the IFN response, the
expression of viral NP was considerably lower in cells infected
with PIV5 wt vM12 than that in cells infected with PIV5 wt vM0
(Fig. 1B and C). This indicates that DIs inhibited the synthesis of
viral proteins expressed from nondefective genomes, which would
likely impact the ability of the virus to antagonize the IFN re-
sponse. Consistent with this finding, “nondefective” PIV5 wt vM0
is unable to inhibit IFN induction by coinfecting DI-rich PIV5 wt
vM12 (Fig. 3A) and PIV5-VC vM2 (Fig. 3B). This was not due to
an inherent inability of the V protein to prevent IFN induction by
DI-related PAMPs generated during these infections, since prein-
fection of A549/pr(IFN-).GFP cells with PIV5 wt was associated
with a significant reduction in GFP expression when subsequently
challenged with PIV5-VC vM2, compared to the level in cells
that had not been preinfected (Fig. 3C). Furthermore, we have
TABLE 2 Trailer copyback DIs in PIV5 wt vM12a
Copyback
junction
(nt position)
DI
genome
size (nt)
Length of
complementary
region (bp)
Length
of loop
(nt)
Obeys
rule of
six?
% of
DI(TrCB)s in
vM12-infected
cells
14496-15062 936 184 568 Yes 94
14380/1-15147/8 966 99 768 Yes 5
14510-14834 1,150 412 326 No (	4) 0.5
Others 
0.5
a DI(TrCB)s in PIV5 wt vM0 versus vM12, 1:87.
TABLE 1 Trailer copyback DIs in PIV5-VC vM2a
Copyback
junction
(nt position)
DI genome
size (nt)
Length of
complementary
region (bp)
Length
of loop
(nt)
Obeys
rule of
six?
% of
DI(TrCB)s in
vM2-infected
cells
14043/4-15023/4b 1,427 223 981 No (	5) 62
14827-15157 510 89 332 Yes 15
14873-15153 468 93 282 Yes 5
14070-15153 1,271 93 1085 No (	5) 3
14338-15107 1,059 139 781 No (	3) 2
Others 13
a DI(TrCB)s in PIV5-VC vM0 versus vM2, 1:22.
b Our original description of this DI of nt 14043 transposed next to nt 15023 (14) was
incorrect due to a data processing error.
Killip et al.
4802 jvi.asm.org Journal of Virology
shown previously that the transient expression of PIV5 V from a
plasmid inhibits IFN induction by a DI-rich IFN-inducing stock
of PIV5-VC (35).
The observation that cells infected with DI-rich preparations
of PIV5 wt expressed high levels of the IFN-upregulated protein
MxA (Fig. 1C and Fig. 4A) suggested that coinfecting DI(TrCB)s
had impaired another function of the V protein: the ability to
target STAT1 for proteasome-mediated degradation to prevent
ISG expression in response to IFN (36). Consistent with this find-
ing, A549/pr(IFN-).GFP cells that had been coinfected with
PIV5 wt vM0 and PIV5-VC vM2 and then subsequently treated
with IFN-, expressed considerable amounts of MxA, indicating
that nondefective PIV5 wt was no longer able to interfere with
STAT1 signaling (Fig. 4B). More specifically, cells that were GFP
positive were also MxA positive and expressed very low levels of
NP. This suggests that DI(TrCB)s had limited nondefective PIV5
replication and protein expression to the extent that the virus was
unable to antagonize either the IFN induction or IFN signaling
cascades.
Given that STAT1 targeting occurs by a catalytic mechanism
(37), whereas V-mediated inhibition of IFN induction occurs ei-
ther through direct binding to mda-5 (19) or by indirectly target-
ing RIG-I through binding to LGP2 (21), the amount of V re-
quired to inhibit IFN signaling is much lower than that required to
inhibit IFN induction. Consistent with this, cells stably expressing
low levels of PIV5 V are completely STAT1 deficient and unable to
respond to IFN (see below), yet are still able to produce IFN (data
not shown). The inability of nondefective virus to inhibit STAT1
signaling in cells infected with DI(TrCB)s therefore suggests that
the level of V in these cells is very low. Indeed, expression of V over
an infection time course is severely impaired in cells coinfected
with PIV5 wt vM0 and PIV5-VC vM2, compared to V expres-
sion during infection with PIV5 wt vM0 alone (Fig. 5). While V
was detected from 6 h postinfection (p.i.) in cells infected with
PIV5 wt vM0, during a coinfection full-length V was only detect-
able in very small amounts from 12 h p.i. In contrast, the IFN
induction cascade was activated very rapidly in coinfected cells,
since the active, phosphorylated form of IRF3 could be detected
from as early as 2 h p.i. Thus, by the time detectable amounts of the
V protein were expressed in these cells, IRF3 had already been
strongly activated by the PIV5-VC DI(TrCB)s and GFP (and
therefore IFN-) had already been expressed.
What was unclear from the data presented in Fig. 5 was
whether the rapid activation of antiviral responses by DI(TrCB)s
was itself responsible for the inhibition of nondefective virus pro-
tein synthesis, by upregulating an ISG product that is inhibiting
nondefective virus replication. In this regard, we have recently
shown that ISG56 is the predominant ISG responsible for the in-
hibitory effect of IFN on PIV5 replication (38). To elucidate the
role of the antiviral response in inhibition of nondefective virus
replication by DI(TrCB)s, we examined the effects of DI(TrCB)s
on virus replication in cells with impaired antiviral responses
(Fig. 6). A549/V cells expressing the V protein of PIV5 are STAT1
deficient and thus unable to respond to IFN (36), while A549/
NPro cells expressing NPro of BVDV, rendering them IRF3 de-
ficient, are thus unable to mount IRF3-dependent antiviral re-
sponses, such as the production of IFN- or ISG56 (26)
(Fig. 6A). Consistent with our previous results, nondefective
virus protein synthesis is markedly reduced in naïve A549 cells
infected with the DI(TrCB)-rich PIV5-VC vM2 stock, with
synthesis of L and M impaired to such an extent that they are
undetectable even following immunoprecipitation (Fig. 6B and
C). In A549/V cells, levels of viral NP and P proteins were
marginally increased compared to A549 cells, while expression
FIG 3 PIV5 wt does not prevent activation of the IFN- promoter by coinfecting copyback DIs, despite encoding an efficient IFN antagonist. (A) A549/pr(IFN-
).GFP cells were infected at an MOI of 10 PFU/cell with PIV5 wt vM0, PIV5 wt vM12, or a 50:50 mixture thereof. The cells were fixed at 20 h p.i., and
GFP-positive cells and the distribution of NP (red), following immunostaining, were visualized by fluorescence microscopy. (B) A549/pr(IFN-).GFP cells were
treated as described above. At 18 h p.i., the cells were trypsinized, fixed, and immunostained for viral NP. Expression of GFP and NP was analyzed by FACS.
Uninfected cells were included as a negative control. (C) Uninfected (UI) A549/pr(IFN-).GFP cells or cells that had been preinfected with PIV5 wt vM0 (at 5
PFU/cell) for 24 h were infected with PIV5-VC vM2. The cells were fixed at 16 h p.i., and GFP was visualized by fluorescence microscopy.
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of NPro increased viral protein synthesis slightly more, as in-
dicated by an increase in NP, P, L, and M expression; however,
nondefective virus replication in these cell lines was still a frac-
tion of the level of replication that occurs in the absence of
DI(TrCB)s. Thus, while impairment of either IFN- or IRF3-
dependent antiviral responses slightly relieved the inhibitory
effect of DI(TrCB)s on nondefective viral protein synthesis,
inhibition of nondefective virus replication by DI(TrCB)s was
largely independent of innate antiviral responses. Taken to-
gether, these data are consistent with a scenario in which
DI(TrCB)s simultaneously and independently both activate
the IFN induction cascade and inhibit nondefective virus rep-
lication. The outcome of this is that the rapid activation of the
IFN induction cascade by DI(TrCB)s occurs prior to the ex-
pression of detectable levels of V by coinfecting nondefective
virus: i.e., insufficient V protein is expressed early enough dur-
ing these infections to limit IFN induction by coinfecting
DI(TrCB)s.
DISCUSSION
In this study, we have extended our previous work on the role of
DIs in IFN induction by PIV5, utilizing powerful deep sequencing
methods to examine DIs in virus preparations. To our knowledge,
this study is the first to analyze deep sequencing data using pro-
grams designed specifically to identify the sites of DI(TrCB)s,
DI(LeCB)s, internal deletions, and duplications. This allowed us
to conduct an extensive analysis of the types of DIs present in virus
stocks, the points in the genome at which these errors were gen-
FIG 4 Copyback DIs impair the ability of PIV5 to limit IFN signaling. (A) Monolayers of A549/pr(IFN-).GFP cells were infected with 1 PFU/cell of PIV5 wt
vM0 or vM9. Cells were fixed at 18 h p.i. and immunostained for MxA and virus NP expression. GFP (green), MxA (blue), and NP (red) were visualized by
confocal microscopy. (B) A549/pr(IFN-).GFP cells were infected with 20 PFU/cell of either PIV5 wt vM0, PIV5-VC vM2, or a mixture of PIV5 wt vM0 and
PIV5-VC vM2. At 8 h p.i., IFN- (1,000 IU/ml) was added to the culture medium and the cells were fixed at 24 h p.i. Following immunostaining, GFP (green),
MxA (blue), and NP (red) were visualized by confocal microscopy.
FIG 5 Coinfecting copyback DIs limit expression of the V protein by nonde-
fective PIV5. Replicates of A549/pr(IFN-).GFP cells were infected with PIV5
wt vM0 and PIV5-VC vM2 (5 PFU/cell of each virus; top panel) or PIV5 wt
vM0 alone (5 PFU/cell; bottom panel). Cell lysates were prepared at various
times p.i. (as indicated) and subjected to immunoblotting for phospho-IRF3
(p-IRF3), GFP, PIV5 V (C terminus [C-term.]), and actin.
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erated, and the frequency with which they occurred. Furthermore,
we used these techniques to compare the variation of virus ge-
nomes from virus stocks that are efficient activators of the IFN
response with those that are not. We demonstrated that PIV5
preparations generated by high-multiplicity passage are very effi-
cient at activating the IFN response, regardless of whether the
parental virus encodes a functional IFN antagonist or not. Deep
sequencing of viral genomes revealed a correlation between the
IFN-inducing capacity of a virus stock and the presence of high
numbers of DI(TrCB)s, consistent with previous studies indicat-
ing a role for paramyxovirus DI(TrCB)s in IFN induction (12–15,
39). We identified a range of distinct DI(TrCB)s, and these varied
considerably in the site of the copyback error, the length of the
predicted dsRNA stem, and the size of the DI genome. Further-
more, no major DI(TrCB) species were detected that were present
in both PIV5 wt and PIV5-VC DI-rich preparations. The lack of
conserved copyback points suggested that there is no particular
part of the Tr in which a template switching error is substantially
more likely to occur. This is consistent with a previous study in
which a range of DI(TrCB)s generated during undiluted passage
of PIV5 W3 were cloned and sequenced by conventional methods
(34); these DIs also lacked conservation in the transposition
points, the sizes of the genomes, and the lengths of the dsRNA
stems. None of the DI(TrCB)s identified in the study by Murphy
et al. (34) were found in our sequencing analysis, despite using the
same virus strain and the same cell line for high-multiplicity pas-
sage. Several of the DI(TrCB)s identified in this previous study
contained identical copyback error sites, yet differed in their total
genome length, indicating additional internal deletion errors. The
nature of deep sequencing does not permit identification of these
types of DI(TrCB)s, although we have not yet observed any such
DIs by cloning and conventional sequencing. Given the variation
in the lengths of the dsRNA stem among DI(TrCB)s identified
here and previously, it is highly likely that these DIs will differ in
their ability to activate the IFN response since the ability of dsRNA
to activate RIG-I and mda-5 is dependent on its length (6).
Our analyses also identified small populations of potential
DI(LeCB), internal deletion, and duplication DIs in our virus
preparations. It is possible that some of these are artifacts gener-
ated during the RT-PCR step of the deep sequencing analysis due
to template switching by the reverse transcriptase (40, 41). We are
therefore currently attempting to validate the existence of these
DIs by other methods. However, it is clear that even when present
in low numbers, these DIs could not have contributed signifi-
cantly to the IFN-inducing capacity of the virus preparations since
they were no more prevalent in virus stocks that were efficient IFN
inducers than in the original vM0 stocks. Naturally occurring in-
ternal deletion mutants of Sendai virus have been identified pre-
viously (9, 42, 43), and consistent with our observations, Strahle
and colleagues have shown that a virus stock composed predom-
inantly of internal deletion species was a poorer inducer of IFN
than a stock exclusively containing DI(TrCB)s (12).
It took significantly more passages (between 9 and 12) to gen-
erate a stock that was efficient at inducing IFN for the PIV5 wt
FIG6 Inhibition of nondefective virus replication by copyback DIs is independent of the antiviral response. (A) A549, A549/V, and A549/NPro cells were treated
with IFN- (1,000 IU/ml), infected with PIV5-VC vM2, or left untreated. Cell lysates were prepared after 16 h and subjected to immunoblotting for IRF3,
ISG56, STAT1, PIV5 P, and actin. (B) A549 (-), A549/NPro (N), and A549/V (V) monolayers were infected at an MOI of 5 PFU/cell with PIV5 wt vM0, PIV5-VC
vM0, or PIV5-VC vM2 or were uninfected. At 20 h p.i., the monolayers were radioactively labeled with [35S]methionine for 1 h. Labeled polypeptides in total
cell extracts were immunoprecipitated using monoclonal antibodies to viral NP, P, M, HN, and L proteins and visualized by SDS-PAGE analysis and autora-
diography. (C) Autoradiogram of total cell extracts used in panel B. (D) Coomassie staining of total cell extracts used in panel B. The positions of the viral proteins
are indicated.
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than it did for PIV5-VC (which required only 2 passages). The
reasons for this are unclear but are under investigation. The V
protein itself may play a role in regulating DI generation, leading
to PIV5-VC accumulating DIs at a higher rate than PIV5 wt. In
this regard, V is known to be able to interact with RNA (44) and
the viral NP and P proteins (45). In addition, V has been reported
to regulate PIV5 transcription and replication (46) and to limit the
synthesis of aberrant RNAs that may otherwise activate antiviral
responses (47, 48). V may also affect the properties of the DIs
generated, since the major DI(TrCB) identified in PIV5-VC
preparations failed to obey the rule of six (dictating that genome
lengths divisible by 6 are more efficiently replicated than those
that are not [34]), whereas the major DI(TrCB) in the PIV5 wt
vM12 preparation did obey this rule.
Although the V protein is able to inhibit IFN- induction by
PIV5 DI-derived PAMPs, it is only able to do so if present in
sufficiently large amounts before DI virus PAMPs are detected.
During our PIV5 wt vM12 infections, and during coinfections of
PIV5 wt vM0 and DI-rich virus preparations, interference from
coinfecting DI(TrCB)s had impaired the replication of nondefec-
tive PIV5 wt (and therefore V protein expression) to the extent
that it failed to block the induction of IFN or IFN signaling by
DI(TrCB)-related PAMPs. In cells in which DI(TrCB) are initially
generated, however, the levels of V synthesized by nondefective
virus prior to copyback generation (and therefore any interference
with nondefective virus replication) are likely to be sufficient to
prevent activation of the IFN induction cascade. We have previ-
ously presented compelling evidence that neither viral genome
replication nor viral protein synthesis is required for IFN induc-
tion by DI-rich preparations of several paramyxoviruses (49).
Thus, in this system, we suggest that the IFN induction cascade
would normally be activated only if a nondefective virus fails to
generate sufficient V protein quickly enough to block activation of
the IFN induction cascade by coinfecting DI(TrCB) or in cells
infected with DI(TrCB)s in the absence of a coinfecting nondefec-
tive virus.
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